Shrinking lung refers to a rare complication of systemic lupus erythematosus and is characterized by unexplained dyspnea, a restrictive pattern in lung function tests, and elevation of the diaphragmatic hemicuples. It is postulated to have a predilection for female involvement and occurs mainly during late stages of the disease. Chest X-rays usually show small, diaphragmatic lungs.
Introduction
The diagnostic interpretation of the findings of Systemic Lupus Erythematosus requires that the examiner be familiar with the imaging spectra of this pathology. Shrinking lung is one of those findings and of importance for the course of the disease, because its early recognition may bring additional therapeutic substrates to the patient. Computed tomography of the chest is the reference method for the identification of these anomalies and their repercussions.
Shrinking lung syndrome (SLS) was first described as a complication of systemic lupus erythematosus (SLE) by Hoffbrand and Beck [1] . The term identifies a constellation of respiratory manifestations including dyspnea, reduced lung volumes and/or elevated hemidiaphragms on chest radiography (CXR), and a restrictive ventilatory defect assessed by pulmonary function tests (PFTs). Serial CXRs demonstrate steadily declining lung volumes as SLS patients become more dyspneic, rendering the impression that the lungs are vanishing. SLS is rare, with an estimated prevalence of <1% among patients with SLE, though several recent reports have suggested a higher prevalence [2] [3] [4] . The syndrome has been reported in other rheumatologic disorders including scleroderma, Sjögren's syndrome, rheumatoid arthritis, and undifferentiated connective tissue disorder [5] [6] [7] [8] . The pathogenesis of SLS remains unknown. Chest imaging shows no evidence of interstitial lung disease or vascular pathology, although chest pain and small pleural effusions are common [9] . While patients may become markedly dyspneic, mortality is rare.
Objective of the Study
The objective of this study was to describe the main imaging findings in Shrinking Lung, an important pulmonary alteration in lupus patients. We highlight the characteristics observed on radiography and computed tomography, with an emphasis on computed tomography. It is important that every radiologist is prepared to recognize these findings and understand the possible clinical repercussions.
Patients and Methods
The study selected patients with systemic lupus erythematosus in our general Table 1 .
Results

Discussion
Systemic lupus erythematosus (SLE) is a diffuse connective tissue disease that presents innumerable clinical manifestations. Involvement of the respiratory tract may occur in more than 50% of patients at some stage of the disease, and the upper airways, pleura, parenchyma, and pulmonary vessels may be involved [10] (Figure 1 and Figure 2) .
A rare manifestation of this disease is Shrinking Lung, the so-called shrinking lung syndrome (SPE), which is characterized by dysfunction of the respiratory muscles, specifically the diaphragm, by mechanisms not yet well defined, leading to dyspnea [10] (Figure 3 (a) and Figure 3(b) ). SPE is a rare clinical condition, classically described in patients with SLE [11] , and rarely in patients with other diseases [8] . It is characterized by the appearance of dyspnea and ventilatory chest pain depending on the changes seen in the pulmonary function tests, which shows restrictive ventilatory disorder, sometimes severe, and radiological findings where there is evidence of unilateral or bilateral diaphragmatic elevation and absence/minimal parenchymal involvement [8] (Figures 4(a)-(c) ).
The pathogenesis of SPE is controversial. There is a suggestion that there is primarily a dysfunction of the diaphragmatic muscles [12] , a hypothesis not always accepted by other authors [9] , diaphragmatic paralysis secondary to phrenic nerve injury, diffuse fibrosis of the diaphragm [13] , or restriction of chest wall expansion by other factors [9] .
Treatment of SPE is also not defined. In the cases described in the world literature, were used corticosteroids [14] [15], immunosuppressants [10] , inhalational beta-agonists (because of the positive inotropic effect of this substance on diaphragmatic muscle receptors) [16] , xanthines [17] and even digitalis (based on the argument of which diaphragm would respond to this drug in a similar way to heart muscle) [18] . 
